Olym­pus gives lo­cal ex­ecs global roles

Abia, Leb­itz, Miller will re­main based in Cen­ter Val­ley af­ter as­sum­ing new du­ties

The Morning Call - - NATION & WORLD - By Jon Har­ris

ABOUT OLYM­PUS

Olym­pus Corp. of Ja­pan is un­der­go­ing some changes, aim­ing to drive cost sav­ings and gen­er­ate growth through the strong U.S. mar­ket for med­i­cal de­vices.

That point was re­in­forced Fri­day, when the com­pany an­nounced it was el­e­vat­ing sev­eral executives at Olym­pus Corp. of the Amer­i­cas in Cen­ter Val­ley to senior-level global roles.

That in­cludes Na­cho Abia, pres­i­dent and CEO of Olym­pus Corp. of the Amer­i­cas. Abia will keep that po­si­tion but also as­sume the role of co-head of the newly cre­ated Ther­a­peu­tic So­lu­tions divi­sion. Abia also will be re­spon­si­ble for global busi­ness devel­op­ment across the med­i­cal, sci­en­tific and imag­ing units of Olym­pus.

In ad­di­tion, Richard Leb­itz, the ex­ec­u­tive direc­tor of in­ter­nal au­dit for Olym­pus Corp. of the Amer­i­cas, has been ap­pointed to serve as the global chief in­ter­nal au­dit of­fi­cer of Olym­pus. Lastly, Mark Miller, Olym­pus Corp. of the Amer­i­cas' vice pres­i­dent of cor­po­rate and med­i­cal com­mu­ni­ca­tions, will serve as the com­pany's global chief com­mu­ni­ca­tions of­fi­cer and the re­gional head of com­mu­ni­ca­tions for the Amer­i­cas.

The three pro­mo­tions are ef­fec­tive April 1. Abia, Leb­itz and Miller will re­main based in Cen­ter Val­ley.

“My col­leagues and I are de­lighted to as­sume our new global roles within Olym­pus, which con­tin­ues to adapt to meet the needs of the rapidly chang­ing in­ter­na­tional mar­kets,” Abia said in a state­ment.

“In our new po­si­tions, we look for­ward to lev­er­ag­ing the ex­pe­ri­ence and ex­per­tise we have de­vel­oped at Olym­pus Corp. of the Amer­i­cas in or­der to sup­port Olym­pus' world­wide growth and to ex­e­cute the com­pany's in­creas­ingly global vi­sion.”

News of the pro­mo­tions came a day af­ter Olym­pus an­nounced a “com­pre­hen­sive trans­for­ma­tion pro­gram to con­tinue its devel­op­ment as a global med­i­cal tech­nol­ogy com­pany and drive im­proved per­for­mance, ac­cel­er­at­ing value cre­ation for all stake­hold­ers.”

The nearly 100-year-old com­pany also is nom­i­nat­ing three new board mem­bers, in­clud­ing D. Robert Hale, a part­ner at U.S. hedge fund ValueAct Cap­i­tal. ValueAct, Olym­pus' largest share­holder, be­gan build­ing a stake in the com­pany more than a year ago, Reuters re­ported.

Fur­ther, Olym­pus Vice Pres­i­dent and Chief Fi­nan­cial Of­fi­cer Ya­suo Takeuchi will be named com­pany pres­i­dent and CEO. Cur­rent Pres­i­dent Hiroyuki Sasa will tran­si­tion to board direc­tor, as of April 1.

One ma­jor part of the re­or­ga­ni­za­tion is the sim­pli­fi­ca­tion of Olym­pus' med­i­cal de­vice busi­ness from five parts into two global di­vi­sions: En­do­scopic So­lu­tions and Ther­a­peu­tic So­lu­tions.

The En­do­scopic So­lu­tions divi­sion, a leader in en­do­scopes, will con­tinue to be man­aged from Ja­pan.

But the Ther­a­peu­tic So­lu­tions unit will be man­aged from the United States by Abia and fel­low co-head To­mo­hisa “Tomo” Saku­rai, who moved from Tokyo to Cen­ter Val­ley in the fall.

That al­lows the divi­sion, which con­sists of sin­gle-use ther­a­peu­tic de­vices for the gas­troin­testi­nal and res­pi­ra­tory fields, along with urol­ogy, gyne­col­ogy and ear, nose and throat prod­ucts, to be lo­cated in the largest ther­a­peu­tic de­vice mar­ket with bet­ter ac­cess to cus­tomers.

Olym­pus Corp. of the Amer­i­cas, which re­lo­cated from Long Is­land, N.Y., to Cen­ter Val­ley in 2006, has about 1,000 em­ploy­ees across two Le­high Val­ley fa­cil­i­ties.

The com­pany's Cen­ter Val­ley head­quar­ters han­dles sales, mar­ket­ing, man­age­ment and sup­port ser­vices for North and South Amer­ica, and Olym­pus also has a dis­tri­bu­tion cen­ter in Breinigsville.

jon.har­[email protected] Twit­ter @ByJonHar­ris 610-820-6779

MORN­ING CALL FILE PHOTO

Na­cho Abia, pres­i­dent and CEO of Olym­pus Corp. of the Amer­i­cas, will also as­sume the role of co-head of the newly cre­ated Ther­a­peu­tic So­lu­tions divi­sion as part of an on­go­ing trans­for­ma­tion with Ja­pan-based Olym­pus Corp.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.